Objective:
To assess the impact of oral contraceptives on lower urinary tract dysfunction in premenopausal women.
Design-Subjects:
A cohort study of 10,791 women (born 1959-1985) from the population-based Swedish Twin Register who participated in a web-based survey of common diseases.
Setting:
National Register.
Intervention(s):
None.
Main Outcome Measure(s):
Symptoms of urinary incontinence.
Result(s):
For users of oral contraception there was a significantly reduced risk for symptoms of stress urinary incontinence (OR 0.57, 95% CI 0.41- 0.79); mixed urinary incontinence (OR 0.52, 95% CI 0.31-0.89); and urgency urinary incontinence (OR 0.36, 95% CI 0.14-0.92). The reduction remained significant when adjusting for age, body mass index and pregnancy history. A reduced prevalence of symptoms of overactive bladder in oral contraceptive users was also observed although the association was non-significant (OR 0.97, 95% CI 0.79-1.18). There were no significant associations between lower urinary tract symptoms and women using a levonorgestrel-releasing intrauterine device compared to non-contraceptive users, with the exception of nocturia (OR 0.53, 95% CI 0.32-0.89).
Conclusion(s):
Oral contraceptive use reduces the overall risk for symptoms of urinary incontinence.